The new germanium compound of caffeic acid, (1), has been obtained to compare anti-tumor activities with 3-(2, 8, 9-trioxa-aza-1-germatricyclo[3. 3. 3. 0]undecane-1-yl)-hydroxycinnamic acids which have been researched previously. Compound was prepared which mainly used caffeic acid, germanium dioxide, sodium hypophosphite, triethanolamine as materials by reducing reaction, Micheal addition reaction and transesterification. The structure is comfirmed by (1)H-NMR and MS. Biological investigation has demonstrated that the compound is stronger anti-tumor activity than 3-(2, 8, 9-trioxa-aza-1-germatricyclo[3. 3. 3. 0]undecane-1-yl)-hydroxylcinnamic acids with lower toxicity.
In this study, the novel germatrane compound, 3-(2, 8, 9-trioxa-5-aza-1- germatricyclo [3.3.3.0] undecane-1-yl)-3-(4-hydroxy-3- methoxyphenyl)-propionic acid (1), has been synthesized and its activities against cervical tumor U14 were evaluated in vitro and in vivo. The results have demonstrated that the compound posed significant inhibition on U14 tumor with IC(50) values of 48.57 mg/L in cell-based assay and tumor inhibitory rates of 38.50%, 47.17% and 64.02% (from low dose to high dose) in animal experiment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.